首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
【24h】

Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.

机译:在血浆或添加剂溶液中输注浓缩血小板后的反应和血小板增加:一项前瞻性随机研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Reactions after platelet transfusions are rather common and frequently are caused by plasma constituents. In recent developments, the preparation and storage of platelet concentrates (PCs) in a platelet additive solution (PAS-2) have been shown to result in acceptable storage conditions. A major drawback of the use of these PCs is the progressive increase of P-selectin-positive platelets during storage. The clinical benefit of transfusions of PCs in PAS-2 was studied. STUDY DESIGN AND METHODS: PCs prepared from buffy coats were suspended in either plasma or PAS-2 and stored for up to 5 days. Clinical responses were evaluated in a prospective study in 21 patients treated with intensive chemotherapy for hematologic malignancies. Eligible patients were randomly assigned to receive prophylactic transfusions of PCs prepared in either plasma or PAS-2. Reactions and CCIs were recorded after each transfusion. RESULTS: The incidence of reactions in 12 patients given PCs in plasma (n = 192) was 12 percent. Transfusions to 9 patients of PCs in PAS-2 (n = 132) showed a reduction in the incidence of reactions to 5.3 percent (p<0.05). The average 1-hour and 20-hour CCIs after transfusion of PCs in plasma were 20.7 +/- 8. 5 and 11.5 +/- 8.0, respectively. CCIs after transfusion of PCs in PAS-2 were significantly lower: the average 1-hour CCI was 17.1 +/- 6.6 (p<0.001) and the average 20-hour CCI was 9.5 +/- 7.0 (p<0.05). Storage conditions of PCs were optimal: in each group, average 1-hour CCIs of both fresh and stored PCs were similar. The 20-hour CCIs after the transfusion of fresh and stored PCs in PAS-2 also were similar. CONCLUSION: Transfusion of PCs in PAS-2 significantly reduces the incidence of reactions. The 1-hour and 20-hour CCIs after transfusion of PCs in PAS-2 were significantly lower than the CCIs after transfusion of PCs in plasma. Because storage conditions of both PCs were found to be optimal, the decrease in CCIs after transfusion of PCs prepared in PAS-2 may be caused by rapid elimination of a subpopulation of P-selectin-positive platelets from the circulation.
机译:背景:血小板输注后的反应相当普遍,并经常由血浆成分引起。在最近的发展中,已经表明在血小板添加剂溶液(PAS-2)中制备和浓缩血小板浓缩物(PC)可以产生可接受的储存条件。使用这些PC的主要缺点是在储存过程中P-选择蛋白阳性血小板的逐渐增加。研究了在PAS-2中输注PC的临床益处。研究设计和方法:将由血沉棕黄层制成的PC悬浮在血浆或PAS-2中,并保存长达5天。在一项前瞻性研究中对21例接受血液循环恶性肿瘤强化化疗的患者的临床反应进行了评估。符合条件的患者被随机分配接受预防性输注血浆或PAS-2中制备的PC。每次输血后记录反应和CCI。结果:血浆中PC的12例患者的反应发生率(n = 192)为12%。在PAS-2中向9例PC患者输血(n = 132)显示反应发生率降低到5.3%(p <0.05)。在血浆中输注PC后,平均1小时和20小时CCI分别为20.7 +/-8。5和11.5 +/- 8.0。在PAS-2中输注PC后的CCI显着降低:平均1小时CCI为17.1 +/- 6.6(p <0.001),平均20小时CCI为9.5 +/- 7.0(p <0.05)。 PC的存储条件是最佳的:在每个组中,新鲜PC和存储PC的平均1小时CCI相似。在PAS-2中输注新鲜和储存的PC后的20小时CCI也相似。结论:在PAS-2中输注PC可显着降低反应的发生率。在PAS-2中输注PC后1小时和20小时的CCI显着低于在血浆中输注PC后的CCI。因为发现两台PC的存储条件都是最佳的,所以从PAS-2中制备的PC输血后CCI的降低可能是由于循环中P-选择素阳性血小板亚群的快速消除所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号